264: Messy PBM conflicts, debatable vaccines, & the future of flu season

1

Introduction

00:00 • 2min

2

The Conflict of Interests in Drug Pricing

01:39 • 3min

3

The Process for Uncovering PBM Relationships

04:10 • 2min

4

The Reaction to Your Story

05:44 • 2min

5

The Consequences of Drug Pricing and Supply Chains

08:08 • 2min

6

The Consequences of Regulatory Reform for PBMs

09:55 • 2min

7

Why Employers Fire Consultants

12:07 • 2min

8

Blockchain or AI: How Does It Solve This?

14:18 • 2min

9

The FDA's Decision to Update COVID Vaccines to Cover Just One Currently Circulating Strain of the Virus

15:52 • 1min

10

The Role of COVID in the Pandemic

17:21 • 3min

11

The VRPAC Meeting Beyond the Dramaturgy of Peter Marks' Zoom Window

19:52 • 2min

12

The CDC's Vaccine Advisors Discuss RSV

21:51 • 1min

13

The CDC's Advisory Committee Vote on Vaccines

23:15 • 2min

14

The Cost of Vaccines

25:23 • 2min

15

The Committee's Dissatisfaction With the Outcome of Yesterday's Vote

27:46 • 2min

16

The Committee's Concerns About RSV Vaccines

29:27 • 2min

17

The Role of RSV and Flu in Seniors' Immune Responses

31:25 • 3min

18

The Challenge of Using RSV Vaccines Properly

34:19 • 2min